Background & Goals Individuals with inflammatory bowel disease are at risk of developing colorectal malignancy (CRC). would prevent tumor development and improve genomic stability. Methods CRC cells with different genetic backgrounds such as HT29 HCT116 HCT116p53?/? HCT116+chr3 and LoVo were treated with 5-ASA for 2-96 hours. Cell cycle progression phosphorylation and DNA binding of cell… Continue reading Background & Goals Individuals with inflammatory bowel disease are at risk